耐火性喘的分子途径和潜在的治疗点
Leah Ishmael1, Thomas Casale2, Juan Carlos Cardet2
1Division of Pulmonary, Allergy, and Sleep Medicine, Mayo Clinic, Jacksonville, FL 32224, USA.
Biology
|August 28, 2024
概括
耐火性喘耐标准治疗,涉及复杂的T2和非T2炎症途径. 了解这些分子通路是开发新疗法的关键,用于严重喘患者,这些患者对当前的治疗没有反应.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 喘是一种慢性炎症性肺病.
- 耐火性喘存在管理方面的挑战,因为它对标准疗法的耐药性.
- 了解耐火性喘的分子基础对于治疗进步至关重要.
研究的目的:
- 审查参与耐火性喘的分子途径.
- 讨论目前和研究中的耐火性喘治疗点.
- 突出需要个性化治疗策略的需要.
主要方法:
- 在耐火性喘中分子途径的文献综述.
- 对T2和非T2炎症机制的分析.
- 对治疗点的检查,包括小分子抑制剂和单克隆抗体.
主要成果:
- 耐火性喘涉及T2 (Th2,ILC2,IL-4,IL-5,IL-13) 和非T2 (中性粒细胞,巨细胞,IL-1,IL-6,IL-17) 途径.
- 警示剂 (IL-25,IL-33,TSLP) 和OX40L显示T2和非T2炎症之间的重叠.
- 研究性疗法针对耐药性喘的途径和调解者,一些患者仍然没有反应.
结论:
- 耐火性喘的多样性需要确定针对性干预的特定媒介.
- 目前正在研究针对巨细胞,IL-1,IL-6,IL-33,TNFα和OX40L的新疗法.
- 基于分子见解的个性化治疗方法对于管理复杂耐火性喘至关重要.
更多相关视频
相关概念视频
Asthma: Pathogenesis and Management
374
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
374
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
251
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
251
Antiasthma Drugs: Leukotriene Modifiers
253
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
253
Drugs Used in Lower Respiratory Disorders: Overview
362
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
362
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K


